Geron Corp reports results for the quarter ended in March - Earnings Summary

Geron

03/05/2024 17:40

* Geron Corp  GERN.OQ  reported a quarterly adjusted loss
of 9
cents​​ per share for the quarter ended in March, lower than the
same quarter last year, when the company reported EPS of -7
cents.  The mean expectation of seven analysts for the quarter
was for a loss of 10 cents per share. Wall Street expected
results to range from -10 cents to -9 cents per share.
    * Revenue rose 1,347.6% to $304.00 thousand from a year ago;
analysts expected $24.71 thousand. 
    * Geron Corp's reported EPS for the quarter was a loss of 9
cents​.
    * The company reported a quarterly loss of $55.39 million.
    * Geron Corp shares had risen by 19.7% this quarter and
gained 87.2% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 16.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Geron Corp is
$5.00 
This summary was machine generated from LSEG data May 3 at 04:40
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.10          -0.09          Beat
 Dec. 31 2023      -0.10          -0.09          Beat
 Sep. 30 2023      -0.10          -0.08          Beat
 Jun. 30 2023      -0.08          -0.09          Missed